Does RANIBIZUMAB Cause Ocular hyperaemia? 316 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 316 reports of Ocular hyperaemia have been filed in association with RANIBIZUMAB (CIMERLI). This represents 2.1% of all adverse event reports for RANIBIZUMAB.
316
Reports of Ocular hyperaemia with RANIBIZUMAB
2.1%
of all RANIBIZUMAB reports
1
Deaths
58
Hospitalizations
How Dangerous Is Ocular hyperaemia From RANIBIZUMAB?
Of the 316 reports, 1 (0.3%) resulted in death, 58 (18.4%) required hospitalization, and 4 (1.3%) were considered life-threatening.
Is Ocular hyperaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANIBIZUMAB. However, 316 reports have been filed with the FAERS database.
What Other Side Effects Does RANIBIZUMAB Cause?
Death (2,250)
Off label use (1,467)
Visual acuity reduced (1,342)
Visual impairment (1,185)
No adverse event (1,012)
Drug ineffective (831)
Blindness (760)
Vision blurred (711)
Eye pain (632)
Cerebrovascular accident (543)
What Other Drugs Cause Ocular hyperaemia?
DUPILUMAB (6,938)
CYCLOSPORINE (1,508)
BIMATOPROST (1,447)
CENEGERMIN-BKBJ (1,226)
BRIMONIDINE (917)
ADALIMUMAB (714)
LATANOPROST (587)
DORZOLAMIDE\TIMOLOL (581)
LIFITEGRAST (570)
TRAVOPROST (478)
Which RANIBIZUMAB Alternatives Have Lower Ocular hyperaemia Risk?
RANIBIZUMAB vs RANIMUSTINE
RANIBIZUMAB vs RANITIDINE
RANIBIZUMAB vs RANITIDINE\RANITIDINE
RANIBIZUMAB vs RANOLAZINE
RANIBIZUMAB vs RAPAMUNE